Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 118INDUSTRY 43NIH 20UNKNOWN 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 64Sarcoma 17Genitourinary 5Dermatologic 5Gynecologic 4Lymphoid 3Other hematologic neoplasm 2Gastrointestinal 2Thoracic 1Head & Neck 1Breast 1

Conditions

Breast Neoplasms 265Breast Neoplasms, Male 20Breast Carcinoma In Situ 15Carcinoma, Non-Small-Cell Lung 13Prostatic Neoplasms 12Carcinoma, Intraductal, Noninfiltrating 12Neoplasm Metastasis 11Lung Neoplasms 11Carcinoma, Ductal, Breast 11Pain 9Colorectal Neoplasms 9Colonic Neoplasms 9Neoplasms 8Inflammatory Breast Neoplasms 8Osteoporosis 7Carcinoma, Ovarian Epithelial 7Triple Negative Breast Neoplasms 6Ovarian Neoplasms 6Fatigue 6Small Cell Lung Carcinoma 5Rectal Neoplasms 5Testicular Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Sezary Syndrome 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Mycosis Fungoides 4Multiple Myeloma 4Melanoma 4Lymphoma, T-Cell, Cutaneous 4

Interventions

Watchful Waiting 1Observation 1Carvedilol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Brain Neoplasms × Breast × Clear all
NCT03418961 2025-10-08

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

SWOG Cancer Research Network

Phase 3 Recruiting
491 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡